Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
BMC Complementary and Alternative Medicine|February 6, 2019
Effects of Radix Linderae extracts on a mouse model of diabetic bladder dysfunction in later decompensated phaseXufeng Yang, Dawei Lian, Pinglong Fan, et al.
Frontiers in Oncology|June 21, 2021
Identification of a Glypican-3 Binding Peptide From a Phage-Displayed Peptide Library for PET Imaging of Hepatocellular CarcinomaJiayao Yan, Xiaoxiao Yu, Xiaotong Chen, et al.
Clinical Endocrinology|December 31, 2021
Mass spectrometry-based cortisol profiling during adrenal venous sampling reveals misdiagnosis for subtyping primary aldosteronismYing Ma, Hong Chen, Fangjun Chen, et al.
Clinical Chemistry and Laboratory Medicine|February 22, 2020
A liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based assay to profile 20 plasma steroids in endocrine disordersZhenxin Wang, Hao Wang, Yingfei Peng, et al.
Cellular Immunology|June 16, 2018
Activation and propagation of tumor-infiltrating lymphocytes from malignant pleural effusion and ascites with engineered cells for costimulatory enhancementQiuping Xu, Jie Shao, Shu Su, et al.
Genomics|June 3, 2023
Testing the generalizability of cfDNA fragmentomic features across different studies for cancer early detectionShu Su, Yulong Xuan, Xiaojun Fan, et al.
Frontiers in Nutrition|April 9, 2026
Clinical application and institutional governance of foods for special medical purposes in medical institutions of eastern coastal China: a cross-sectional studyQingqing Deng, Wanli Pu, Ting Zhu, et al.
Oncotargets and Therapy|December 10, 2019
Immune-Mediated Antitumor Effect By VEGFR2 Selective Inhibitor For Gastric CancerJu Yang, Jing Yan, Jie Shao, et al.
Journal of Proteome Research|June 4, 2025
Lipidomics Facilitates the Discovery of Diagnostic Biomarkers in Patients with Chronic Total Occlusion during the Perioperative PeriodZhenxin Wang, Xin Zhong, Kaidi Wang, et al.
Journal of Medicinal Chemistry|March 29, 2024
Discovery of 2,3-Dihydro[1,4]dioxino[2,3-g]benzofuran Derivatives as Protease Activated Receptor 4 (PAR4) Antagonists with Potent Antiplatelet Aggregation Activity and Low Bleeding TendencyPanpan Chen, Cai Chen, Yizheng Zheng, et al.
Pageof 7